Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2016 02:19 ET | Source: Ziarco Pharma Ltd

Ziarco Pharma Ltd: Ziarco reports positive Phase 2a study results with ZPL-389 in moderate to severe atopic dermatitis patients

Clinically and statistically significant reduction in signs and symptoms of moderate to severe atopic dermatitis 50% (p=0.01) improvement on the eczema severity score (EASI) at week...
May 16, 2016 02:14 ET | Source: Ziarco Pharma Ltd

Ziarco Pharma Announces Positive Top Line Results from Phase 2a Study in Moderate to Severe Atopic Dermatitis with its Oral Lead Compound ZPL-389

50% (p=0.01) improvement on EASI score at week 8 Full data to be presented at the EAACI Congress, 12 June 2016, Vienna, Austria in a Late Breaking Oral Session DISCOVERY PARK, SANDWICH,...